Sign in

Olema Pharmaceuticals, Inc.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.18 0.14 0.10 0.11 0.07 0.02 0.00 0.00
Operating income -0.18 -0.14 -0.10 -0.11 -0.07 -0.02 0.00 0.00
Non-operating income (net) 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Income before tax -0.16 -0.13 -0.10 -0.10 -0.07 -0.02 0.00 0.00
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.16 -0.13 -0.10 -0.10 -0.07 -0.02 0.00 0.00
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.06 0.05 0.05 0.05 0.03 0.04 0.04 0.03 0.03 0.03 0.02 0.02 0.03 0.03 0.02 0.03 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.00 0.00 0.00
Operating income -0.06 -0.05 -0.05 -0.05 -0.03 -0.04 -0.04 -0.03 -0.03 -0.03 -0.02 -0.02 -0.03 -0.03 -0.02 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 0.00 0.00 0.00
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.05 -0.05 -0.04 -0.04 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03 -0.02 -0.02 -0.03 -0.03 -0.02 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 0.00 0.00 0.00
Income tax expense 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00
Net income -0.05 -0.05 -0.04 -0.04 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03 -0.02 -0.02 -0.03 -0.03 -0.02 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.01 0.00 0.00 0.00
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total cash and short-term investments + 0.51 0.43 0.26 0.20 0.29 0.34 0.00 0.00
Accounts receivable, net 0.00 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00
Other current assets 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.52 0.44 0.27 0.21 0.29 0.34 0.00 0.00
Total non-current assets + 0.02 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Total assets 0.53 0.45 0.28 0.22 0.30 0.34 0.00 0.00
Total current liabilities + 0.05 0.04 0.02 0.02 0.01 0.00 0.00 0.00
Total non-current liabilities + 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01
Total liabilities 0.05 0.04 0.02 0.02 0.01 0.00 0.01 0.01
Total stockholders' equity + 0.48 0.41 0.25 0.20 0.28 0.34 -0.01 -0.01
Common shares outstanding 87 59 45 40 40 39 40 14
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19
Total cash and short-term investments + 0.51 0.51 0.33 0.36 0.39 0.43 0.21 0.24 0.25 0.26 0.28 0.17 0.19 0.20 0.22 0.24 0.27 0.29 0.31 0.32 0.33 0.34 0.13 0.00 0.00 0.00
Accounts receivable, net 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00 0.00 0.00
Other current assets 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.51 0.52 0.33 0.37 0.40 0.44 0.22 0.24 0.25 0.27 0.28 0.17 0.19 0.21 0.23 0.24 0.27 0.29 0.31 0.32 0.33 0.34 0.13 0.00 0.00
Total non-current assets + 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total assets 0.53 0.53 0.35 0.38 0.41 0.45 0.23 0.25 0.26 0.28 0.29 0.18 0.20 0.22 0.23 0.25 0.28 0.30 0.31 0.32 0.33 0.34 0.13 0.00
Total current liabilities + 0.05 0.05 0.04 0.03 0.03 0.04 0.03 0.03 0.03 0.02 0.02 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.00
Total non-current liabilities + 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
Total liabilities 0.05 0.05 0.04 0.04 0.03 0.04 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.01
Total stockholders' equity + 0.48 0.48 0.31 0.35 0.38 0.41 0.20 0.23 0.24 0.25 0.28 0.16 0.17 0.20 0.22 0.24 0.27 0.28 0.30 0.31 0.33 0.34 0.13 0.00 -0.01
Common shares outstanding 103 91 86 85 85 59 57 56 56 55 45 41 40 40 40 40 40 40 40 39 39 20 38 14 14 14
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Operating cash flow + -0.15 -0.10 -0.08 -0.08 -0.05 -0.02 0.00 0.00
Cash flow from investing + -0.16 -0.09 0.00 0.09 -0.28 0.00 0.00 0.00
Cash flow from financing + 0.21 0.27 0.13 0.00 0.00 0.36 0.36 0.01
Change in cash -0.09 0.07 0.04 0.01 -0.32 0.34 0.36 0.00
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19
Operating cash flow + -0.05 -0.04 -0.03 -0.03 -0.04 -0.03 -0.03 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.03 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 0.00 0.00 0.00
Cash flow from investing + 0.00 -0.16 0.02 0.03 -0.05 -0.11 0.05 0.00 -0.02 -0.03 -0.03 0.01 0.04 0.02 0.02 0.03 0.03 0.01 -0.01 0.01 -0.28 0.00 0.00 0.00 0.00 0.00
Cash flow from financing + 0.05 0.21 0.00 0.00 0.00 0.24 0.00 0.02 0.01 0.00 0.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.22 0.22 0.08 0.02 0.03 0.22
Change in cash 0.00 0.01 -0.02 0.00 -0.09 0.10 0.02 -0.02 -0.03 -0.05 0.08 -0.01 0.02 0.00 0.00 0.00 0.01 -0.01 -0.02 0.00 -0.07 0.21 0.08 0.02 0.03 0.22
4 days ago

Olema Pharmaceuticals, Inc. (OLMA) - Shares Outstanding Diluted

1Y 2Y 5Y Max
9 days ago

Olema Pharmaceuticals, Inc. (OLMA) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
9 days ago

Olema Pharmaceuticals, Inc. (OLMA) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
9 days ago

Olema Pharmaceuticals, Inc. (OLMA) - Net Income

1Y 2Y 5Y Max
9 days ago

Olema Pharmaceuticals, Inc. (OLMA) - Stock Based Compensation

1Y 2Y 5Y Max
9 days ago

Olema Pharmaceuticals, Inc. (OLMA) - Cashflow From Financing

1Y 2Y 5Y Max
9 days ago

Olema Pharmaceuticals, Inc. (OLMA) - Cashflow From Investment

1Y 2Y 5Y Max
9 days ago

Olema Pharmaceuticals, Inc. (OLMA) - Capital Expenditures

1Y 2Y 5Y Max
9 days ago

Olema Pharmaceuticals, Inc. (OLMA) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
9 days ago

Olema Pharmaceuticals, Inc. (OLMA) - Operating Cashflow

1Y 2Y 5Y Max
9 days ago